LOUISVILLE, Ky. / May 15, 2024 / Business Wire / Humana Inc. (NYSE: HUM) has ascended to No. 6 on Fair360’s prestigious list of the Top 50 Companies for Workplace Fairness, marking its seventh consecutive year in the top rankings. This significant move up from No. 10 last year showcases Humana's dedication to diversity and inclusion, as recognized by one of the nation's most comprehensive analyses of corporate diversity practices.
“Providing high-quality care for our customers is centered on our understanding of the unique experiences that shape their health journey,” said Humana CEO Bruce Broussard. “Advancing equity across the healthcare ecosystem relies on caring for diversity, equity and inclusion across all areas of the company. We remain committed to ensuring this work is part of every aspect of our business.”
Fair360’s Top 50 list is a highly regarded barometer of diversity management practices across corporate America, assessing companies with a minimum of 750 employees based on rigorous data analysis within their respective industries. Humana's high performance on the list is complemented by its strong showing on several of Fair360's Specialty Lists.
In 2023, Humana maintained its diversity, equity, inclusion, and belonging efforts, with key highlights including:
“At Humana, we believe that every individual has a vital role to play in fostering a sense of belonging within our organization,” said Carolyn Tandy, Humana’s Senior Vice President and Chief Diversity, Equity, and Inclusion Officer. “By integrating diversity, equity, and inclusion practices across our company, we empower all employees to thrive and reach their full potential. Our commitment to celebrating diversity and creating an inclusive environment is deeply ingrained in our health-first mission, enabling us to better understand and care for the communities we serve.”
Humana's culture of inclusion and belonging underscores its commitment to creating a workplace where all employees feel valued and empowered to excel. The healthcare company's journey towards equity remains ongoing, steadfastly dedicated to advancing diversity and inclusion for employees, members, patients, and communities.
For more information about Humana’s diversity, equity, and inclusion goals and progress, please read Humana’s 2023 Impact Report.
About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
About Fair360
The mission of DiversityInc is to bring education and clarity to the business benefits of diversity. The DiversityInc Top 50 Companies for Diversity list began in 2001, when many corporations were beginning to understand the business value of diversity-management initiatives. DiversityInc is a VA certified veteran-owned business and a USBLN certified business owned by a person with a disability. For more information, visit www.diversityinc.com.
Last Trade: | US$293.97 |
Daily Change: | 16.19 5.83 |
Daily Volume: | 2,221,854 |
Market Cap: | US$35.400B |
November 12, 2024 October 30, 2024 October 24, 2024 October 23, 2024 August 19, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB